This week, Medline launched the biggest IPO of 2025. But, it wasn't the only large public listing this year, according to a CNBC Pro data analysis.

Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.

This week, Medline launched the biggest IPO of 2025. But, it wasn't the only large public listing this year, according to a CNBC Pro data analysis.